[
  {
    "ts": null,
    "headline": "2 HMO Stocks Poised to Thrive Despite Escalating Medical Costs",
    "summary": "The Medical-HMO industry benefits from strength in commercial plans, M&A and expected Medicare rate hikes, but rising costs, regulatory shifts and workforce shortages strain margins. CI and HUM are likely to navigate industry storms.",
    "url": "https://finnhub.io/api/news?id=7e507cc22612a2cd8f2af5758cb841e632b7dc829ff6ac8d8143fa703dd6420f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758211380,
      "headline": "2 HMO Stocks Poised to Thrive Despite Escalating Medical Costs",
      "id": 136799721,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CI",
      "source": "Yahoo",
      "summary": "The Medical-HMO industry benefits from strength in commercial plans, M&A and expected Medicare rate hikes, but rising costs, regulatory shifts and workforce shortages strain margins. CI and HUM are likely to navigate industry storms.",
      "url": "https://finnhub.io/api/news?id=7e507cc22612a2cd8f2af5758cb841e632b7dc829ff6ac8d8143fa703dd6420f"
    }
  }
]